Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Researchers can use the model to predict how engineered forms of insulin would perform in human patients, making it easier to bring these drugs to clinical trials.
The device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy.
Payton Dupuis finds new scientific interests and career opportunities through MIT summer research program in biology.
A new device, which doesn’t rely on immunosuppressing drugs, may assist efforts to develop an artificial pancreas to treat diabetes.
The MIT anthropologist is recognized for interdisciplinary work on health, climate, and equity.
MIT anthropologist Amy Moran-Thomas reflects on the deep connection between planetary and human well-being.
Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.
A new model can predict which types of glucose-responsive insulin will work in humans and animals.
A week of learning with MIT Bootcamps sparked ideas that Jal Panchal and Maria Hahn are taking forward to solve problems in health care.
Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.
Study may be a step toward shelf-stable versions of the hormone, which is used to control diabetes.
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
Measurements could help scientists develop better designs for a bioartificial pancreas.
Startup develops implantable, encased cells that live in the body and secrete insulin and other therapeutics.